Vantage Capital’s investment in Austell Pharmaceuticals’ operations in South Africa for USD 9.7 million

Lead party: Vantage Capital Fund Managers (Pty) Ltd​ (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Austell Pharmaceuticals (Pty) Ltd (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: South Africa Transaction type: Debt Financing · Asset class: Private Credit · Strategy: Direct Lending · Instrument: Mezzanine…


Lead party: Vantage Capital Fund Managers (Pty) Ltd​ (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Austell Pharmaceuticals (Pty) Ltd (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: South Africa

Transaction type: Debt Financing · Asset class: Private Credit · Strategy: Direct Lending · Instrument: Mezzanine Debt · Deal amount: US$9.7m · Fund: Vantage Mezzanine Fund II

Lead investor/buyer: Vantage Capital Fund Managers (Pty) Ltd​ · Investors/buyers: Vantage Capital Fund Managers (Pty) Ltd​

Legal advisers: not identified in the source record.

Source: announced 12 September 2014. Original announcement: africaglobalfunds.com.